Welcome to our dedicated page for Nice SEC filings (Ticker: NCSYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NICE Ltd. filings document the company's foreign-private-issuer reporting through Form 6-K submissions. The records include furnished press releases and exhibits on GAAP financial statements, cloud revenue, AI annual recurring revenue, share repurchases, and financial outlook, with selected financial statements incorporated by reference into Form S-8 registration statements for equity compensation plans.
The filings also record product and customer announcements for NiCE CXone, NiCE Cognigy, and NICE Actimize, including contact-center-as-a-service, AI agents, interaction analytics, fraud detection, financial-crime risk management, and KYC solutions. Governance disclosures cover special general meeting notices, record dates, proxy and electronic voting mechanics, and instructions for American Depositary Share holders.
NICE Ltd. director David Kostman filed an initial Form 3 reporting his beneficial ownership. He directly holds 19,146 Ordinary Shares, which include 1,744 RSUs and 7,635 ADRs, each ADR representing one Ordinary Share. He also reports multiple option awards over Ordinary Shares, such as options exercisable for 14,920 shares at an exercise price of $151.63 expiring on April 30, 2026 and options for 10,423 shares at $224.18 expiring on September 10, 2026, along with additional grants extending through 2031. The filing records current holdings and does not show new purchases or sales.
NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares. The filing lists multiple option awards with different exercise prices and expiration dates ranging from 2026 through 2031.
Some options, including grants covering ordinary shares at exercise prices such as 224.1800 and 144.9030, are fully vested and currently exercisable. One grant is already exercisable for 746 ordinary shares and is scheduled to vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant will fully vest on September 30, 2026. The form records holdings only and does not report new purchases or sales.
NICE Ltd. director Caroline J. Tsay filed an initial ownership report showing equity awards rather than new share purchases or sales. She holds options linked to 2,987 Ordinary Shares at an exercise price of $144.9030 per share, expiring on September 30, 2031. These options are already vested for 746 Ordinary Shares and will vest for the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. She also holds 746 Restricted Share Units, each representing a contingent right to receive one Ordinary Share, which will vest under the terms of the applicable awards.
NICE Ltd. Chief Financial Officer Mary Beth Gaspich filed an initial ownership report showing her equity stake in the company. She directly holds 62,121 Ordinary Shares, which include 32,615 restricted stock units (RSUs) and 15,910 performance stock units (PSUs), each convertible into one Ordinary Share as they vest under their award terms. She also holds Performance Share Units representing a contingent right to receive 5,000 Ordinary Shares, eligible to vest over a three-year performance period ending February 18, 2029. These units may be earned between 0%-200% of target levels based on the company’s stock price performance against specified thresholds.
NICE Ltd. executive Levy Meir Alon, VP, General Counsel & Corporate Secretary, reports holding stock options tied to 1,800 Ordinary Shares. These options carry an exercise price of 0.3108 and expire on November 11, 2031.
According to the vesting schedule, the option will vest in substantially equal installments on September 1, 2026, September 1, 2027, September 1, 2028 and September 1, 2029. This Form 3 serves as an initial statement of this derivative holding.
NICE Ltd. furnished a Form 6-K highlighting two AI-focused milestones. First, its NiCE Cognigy platform was recognized as the only vendor to receive the Customers’ Choice distinction in the 2025 Gartner Peer Insights Voice of the Customer for Enterprise Conversational AI Platforms, based on verified user reviews and a 4.8/5 rating from 138 ratings as of January 14, 2026.
Second, NICE released The Agentic AI CX Frontline report, which shares live enterprise benchmarks for AI-first customer experience, including 3x faster deployments, containment rates exceeding 80%, double-digit reductions in cost per contact, and customer satisfaction gains of up to 20% for large organizations using Agentic AI at scale.
NICE Ltd. filed its annual Form 20-F describing its business, share capital and extensive risk factors for the year ended December 31, 2025. The company reports 60,427,562 ordinary shares outstanding as of that date, excluding 14,347,265 treasury shares.
The filing highlights intense competition, rapid technology change including AI, reliance on cloud and third‑party infrastructure, and challenges shifting from on‑premises to SaaS and usage-based models. It also details cybersecurity and data-privacy exposure, regulatory and AI-related compliance risks, acquisition and integration risks, and financial risks such as foreign exchange volatility and dependence on tax benefits.
NICE Ltd. filed its annual Form 20-F describing its business, share capital and extensive risk factors for the year ended December 31, 2025. The company reports 60,427,562 ordinary shares outstanding as of that date, excluding 14,347,265 treasury shares.
The filing highlights intense competition, rapid technology change including AI, reliance on cloud and third‑party infrastructure, and challenges shifting from on‑premises to SaaS and usage-based models. It also details cybersecurity and data-privacy exposure, regulatory and AI-related compliance risks, acquisition and integration risks, and financial risks such as foreign exchange volatility and dependence on tax benefits.
NICE reported an insider sale filing. A Form 144 entry lists 1,550 common shares associated with restricted stock vesting under a registered plan, with the transaction dated 02/19/2026. The filing identifies the broker as Morgan Stanley Smith Barney LLC and the market as NASDAQ.
NICE reported an insider sale filing. A Form 144 entry lists 1,550 common shares associated with restricted stock vesting under a registered plan, with the transaction dated 02/19/2026. The filing identifies the broker as Morgan Stanley Smith Barney LLC and the market as NASDAQ.
NICE Ltd. reported solid fourth quarter and full-year 2025 results, led by strong cloud and AI-driven growth. Q4 revenue reached $786.5M, up 9%, with cloud revenue of $608.3M, up 14%. GAAP diluted EPS was $2.41, up 57%, and non-GAAP diluted EPS was $3.24, up 7%.
For 2025, total revenue was $2,945.4M, up 8%, and cloud revenue was $2,238.4M, up 13%. GAAP diluted EPS rose to $9.67, up 43%, while non-GAAP diluted EPS was $12.30, up 11%. AI annual recurring revenue grew 66% year over year to $328M, and AI was included in 100% of new seven-figure CXone deals.
Operating cash flow for 2025 was $716.5M, with free cash flow of $622.8M and $488.9M used for share repurchases. Year-end cash, cash equivalents and short-term investments totaled $417.4M with no outstanding debt. NICE entered a new $300M revolving credit facility maturing in 2029 and its board authorized a new $600M share repurchase program, bringing total remaining repurchase capacity to about $1B. For 2026, NICE guides to non-GAAP revenue of $3,170M–$3,190M (about 8% growth) and non-GAAP EPS of $10.85–$11.05, with cloud revenue expected to grow 14.5–15.0%.
NICE Ltd. reported solid fourth quarter and full-year 2025 results, led by strong cloud and AI-driven growth. Q4 revenue reached $786.5M, up 9%, with cloud revenue of $608.3M, up 14%. GAAP diluted EPS was $2.41, up 57%, and non-GAAP diluted EPS was $3.24, up 7%.
For 2025, total revenue was $2,945.4M, up 8%, and cloud revenue was $2,238.4M, up 13%. GAAP diluted EPS rose to $9.67, up 43%, while non-GAAP diluted EPS was $12.30, up 11%. AI annual recurring revenue grew 66% year over year to $328M, and AI was included in 100% of new seven-figure CXone deals.
Operating cash flow for 2025 was $716.5M, with free cash flow of $622.8M and $488.9M used for share repurchases. Year-end cash, cash equivalents and short-term investments totaled $417.4M with no outstanding debt. NICE entered a new $300M revolving credit facility maturing in 2029 and its board authorized a new $600M share repurchase program, bringing total remaining repurchase capacity to about $1B. For 2026, NICE guides to non-GAAP revenue of $3,170M–$3,190M (about 8% growth) and non-GAAP EPS of $10.85–$11.05, with cloud revenue expected to grow 14.5–15.0%.
NICE Ltd. filed a Form 6-K highlighting multiple AI- and fraud-focused milestones across its NICE Actimize and NiCE CX platforms. The exhibits include analyst recognition, a major European cloud deployment, and new product launches.
NICE Actimize is recognized as a Leader in enterprise fraud management in Asia Pacific by Forrester and as a Luminary in Celent’s 2025 Anti-Fraud Solutionscape, underscoring the breadth of its fraud and financial crime capabilities. NiCE also announces that German health insurer AOK Bayern has deployed the NiCE CXone platform on the EU Sovereign Cloud to modernize service for more than 4.5 million insured members.
Additional exhibits introduce Cognigy Simulator, an AI performance lab for large-scale testing of AI agents, and the Actimize Insights Network, a real-time intelligence network designed to help financial institutions assess counterparty risk and combat scams and financial crime with shared fraud and AML insights.
NICE Ltd. filed a Form 6-K highlighting multiple AI- and fraud-focused milestones across its NICE Actimize and NiCE CX platforms. The exhibits include analyst recognition, a major European cloud deployment, and new product launches.
NICE Actimize is recognized as a Leader in enterprise fraud management in Asia Pacific by Forrester and as a Luminary in Celent’s 2025 Anti-Fraud Solutionscape, underscoring the breadth of its fraud and financial crime capabilities. NiCE also announces that German health insurer AOK Bayern has deployed the NiCE CXone platform on the EU Sovereign Cloud to modernize service for more than 4.5 million insured members.
Additional exhibits introduce Cognigy Simulator, an AI performance lab for large-scale testing of AI agents, and the Actimize Insights Network, a real-time intelligence network designed to help financial institutions assess counterparty risk and combat scams and financial crime with shared fraud and AML insights.